SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Peter Silsbee who wrote (15873)2/25/1998 2:35:00 PM
From: Flagrante Delictu  Read Replies (3) | Respond to of 32384
 
Peter, >> your concern that stock in CYTL might be worthless << First, if one were to consider the broad industry background of the LGND management team, one might conclude that they wouldn't knowingly waste time & resources dealing with an outfit they didn't believe could meet its obligations.

Second, the current issue of CTSL , Michael Murphy's publication, tells its subscribers to , " Buy {CYTL} for a long term target of $60." Bernie